Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:Q86TM3 (
cage
)
29,987
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The connection between signaling pathways activating
cancer-associated
fibroblasts (CAFs) remains to be determined. Metabolic alterations linked to autophagy have also been implicated in CAF activation. CSL/RBPJ, a transcriptional repressor that mediates Notch signaling, suppresses the gene expression program(s), leading to stromal senescence and CAF activation. Deregulated GLI signaling can also contribute to CAF conversion. Here, we report that compromised CSL function depends on GLI activation for conversion of human dermal fibroblasts into CAFs, separately from cellular senescence. Decreased CSL upregulates the expression of the
ULK3
kinase, which binds and activates GLI2. Increased
ULK3
also induces autophagy, which is unlinked from GLI and CAF activation.
ULK3
upregulation occurs in the CAFs of several tumor types, and
ULK3
silencing suppresses the tumor-enhancing properties of these cells. Thus,
ULK3
links two key signaling pathways involved in CAF conversion and is an attractive target for stroma-focused anti-cancer intervention.
...
PMID:The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI. 2887 78